You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Chronic%20Myeloid%20Leukemia

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Asciminib RMP Study

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Asciminib
  • (no location specified)
Jul 5, 2023

Real-World Usage of Asciminib Among Chronic Myeloid Leukemia in

Completed
  • Chronic Myeloid Leukemia
    • East Hanover, New Jersey
      Novartis
    Nov 20, 2023

    Chronic Myelogenous Leukemia - Chronic Phase Trial in Avignon (APN and medical management, Medical management, Quality of life

    Not yet recruiting
    • Chronic Myelogenous Leukemia - Chronic Phase
    • APN and medical management
    • +3 more
    • Avignon, Provence-Alpes-Côte d'Azur, France
      Centre Hospitalier d'Avignon, Hôpital Henri Duffaut
    Oct 13, 2023

    Chronic Myeloid Leukemia Any Phase Treated With Ponatinib at Any

    Active, not recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
      • Jena, Germany
        University Hospital Jena
      Jan 17, 2023

      Tyrosine Kinase Inhibitors, Chronic Myeloid Leukemia Trial in Poitiers (treatment of TKI in CML)

      Not yet recruiting
      • Tyrosine Kinase Inhibitors
      • Chronic Myeloid Leukemia
      • treatment of TKI in CML
      • Poitiers, France
        Chu Poitiers
      Feb 21, 2023

      Ponatinib in CML Patients in Chronic Phase

      Recruiting
      • Chronic Myeloid Leukemia, Chronic Phase
      • Therapeutic drug monitoring
      • Molecular Response
      • Cagliari, Italy
      • +4 more
      Nov 3, 2023

      Chronic Myeloid Leukemia in Myeloid Blast Crisis, Chronic Myeloid Leukaemia Transformation, Chronic Myeloid Leukemia -

      Recruiting
      • Chronic Myeloid Leukemia in Myeloid Blast Crisis
      • +3 more
      • based decitabine and olverembatinib（HQP1351)chemotherapy
      • Guanzhou, China
        Department of Hematology, Nanfang Hospital, Southern Medical Uni
      Dec 6, 2022

      Chronic Myeloid Leukemia (CML) Trial in France

      Recruiting
      • Chronic Myeloid Leukemia (CML)
        • Annecy, France
        • +11 more
        Jul 18, 2023

        CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

        Recruiting
        • CML
        • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
        • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
          FUNDALEU
        Jun 29, 2023

        3L+ Therapies Among Chronic Myeloid Leukemia and Those With

        Completed
        • Chronic Myeloid Leukemia
          • East Hanover, New Jersey
            Novartis Investigative Site
          Nov 11, 2022

          Chronic Myeloid Leukemia, BCR/ABL-Positive Trial in Taipei

          Not yet recruiting
          • Chronic Myeloid Leukemia, BCR/ABL-Positive
            • Taipei, Taiwan
              National Taiwan University Hospital
            Jul 24, 2022

            CML, Chronic Phase, CML, Accelerated Phase Trial in Wuhan (HS-10382(Part 1: Dose escalation), HS-10382(Part 2: Dose expansion))

            Recruiting
            • CML, Chronic Phase
            • CML, Accelerated Phase
            • HS-10382(Part 1: Dose escalation)
            • HS-10382(Part 2: Dose expansion)
            • Wuhan, Hubei, China
              Union Hospital affiliated to Tongji Medical College of Huazhong
            Jan 12, 2023

            Information of Ponatinib, Bosutinib, Imatinib, Dasatinib and

            Completed
            • Leukemia
            • No Intervention
            • Cambridge, Massachusetts
              Takeda
            Feb 28, 2023

            "Peripheral Blood Dipeptidylpeptidase IV Positive Leukemic Stem

            Not yet recruiting
            • Chronic Myeloid Leukemia, Chronic Phase
              • Sohag, Egypt
                Sohag University Hospital
              Sep 14, 2022

              Landscape and Real-life Treatment Outcomes in Hungary: Analysis

              Completed
              • Chronic Myeloid Leukaemia
              • Budapest, Hungary
                Pfizer
              Dec 15, 2022

              Chronic Myeloid Leukemia, Chronic Phase, Adult CML, Leukemia, Myeloid Trial in Augusta, Milwaukee (Asciminib, Ascimininb +

              Recruiting
              • Chronic Myeloid Leukemia, Chronic Phase
              • +3 more
              • Augusta, Georgia
              • +1 more
              Jul 14, 2022

              Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia Trial (Miltenyi CliniMACS Prodigy ®

              Not yet recruiting
              • Acute Lymphoblastic Leukemia
              • +6 more
              • Miltenyi CliniMACS Prodigy ® system
              • (no location specified)
              Mar 23, 2023

              sCD62L and SPARC in Chronic Myeloid Leukemia Patients During

              Completed
              • Chronic Myeloid Leukemia
              • ELISA kit
              • Tanta, Egypt
                Tanta University
              May 18, 2022

              Chronic Myeloid Leukemia, Chronic Phase, Withdrawal;Drug Trial in Czechia (Imatinib withdrawal, Dasatinib, Nilotinib)

              Recruiting
              • Chronic Myeloid Leukemia, Chronic Phase
              • Withdrawal;Drug
              • Imatinib withdrawal
              • +2 more
              • Brno, Czechia
              • +7 more
              Aug 24, 2022

              Condition Vasoregulation Function Endothelium in CML Getting TKI

              Recruiting
              • Chronic Myeloid Leukaemia
              • taking blood for the study of biochemical parameters and the study of microcirculation using the method of laser Doppler flowmetry
              • Moscow, Russian Federation
              • +1 more
              Jan 11, 2023

              Olverembatinib, Chronic Myeloid Leukemia, Chronic Phase, Tyrosine Kinase Inhibitors Trial in Shenzhen (olverembatinib)

              Recruiting
              • Olverembatinib
              • +2 more
              • Shenzhen, Guangdong, China
                Shenzhen Second People's Hospital
              Jul 26, 2022

              According to Molecular Identification at Diagnosis

              Not yet recruiting
              • Chronic Myeloid Leukemia
              • Next Generation Sequencing (DNA and RNA)
              • (no location specified)
              Oct 28, 2022

              Effect of Pharmacogenetics on Imatinib Plasma Level and Response

              Active, not recruiting
              • Chronic Myeloid Leukemia
              • PCR
              • HPLC-UV
              • Assiut, Egypt
                South Egypt Cancer Institute
              Aug 6, 2022

              Chronic Phase Chronic Myelogenous Leukemia, Philadelphia Chromosome Positive, BCR-ABL1 Positive Chronic Myelogenous Leukemia

              Recruiting
              • Chronic Phase Chronic Myelogenous Leukemia
              • +3 more
              • Houston, Texas
                M D Anderson Cancer Center
              Aug 11, 2022

              Chronic Myeloid Leukemia in Chronic Phase Trial in Shenzhen (Flumatinib, Dasatinib)

              Recruiting
              • Chronic Myeloid Leukemia in Chronic Phase
              • Shenzhen, Guangdong, China
                Shenzhen Second People's Hospital
              Jul 26, 2022